Deep brain stimulation is FDA-approved and has been used for years to treat patients with advanced Parkinson’s disease (PD) who have severe levodopa-induced motor complications.1 New evidence from a controlled trial suggests that it may also be effective for patients with PD and early motor complications.
Once a month, JAMA selects for publication one article previously published in The Medical Letter.
Previous Publication: This article was previously published: The Medical Letter. October 14, 2013;55(1427):81-82.
©The Medical Letter Inc.
About The Medical Letter: The Medical Letter is a nonprofit organization that publishes biweekly new drug evaluations and treatment recommendations. The Medical Letter does not accept advertisements, gifts, grants, or donations. Financial support comes solely from sales of subscriptions, books, software, continuing education materials, and licenses.
Editors: Mark Abramowicz, MD, Editor in Chief; Gianna Zuccotti, MD, MPH, Executive Editor; Jean-Marie Pflomm, PharmD, Editor